Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


BioTech Pharma Summit: Biosimilars & Biologics 2018

The Future of the Biotech medicines

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including: Biologics/Biotechnology/ Biogenerics Biopharmaceuticals Business Development Chief Scientific Officer Clinical Immunology Commercial Affairs Drug and Safety Assessment Drug Safety & Risk Management Intellectual property Legislation and Policy Advice Manufacturing Market Strategy Marketing & sales New Product Development Pharmacovigilance Preclinical and Clinical Development Pricing and Reimbursement Health Economics Principal Scientist Process Control and Analytical Technologies Quality Affairs/ Quality Control Regulatory Affairs Regulatory Compliance Legal Affairs R & D


On 22 & 23 March 2018, Porto will host the 2nd BioTech Pharma Summit: Biosimilars & Biologics 2018. This year’s flagship event will gather top EU, US, Asia and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilars & biologics medicines sector.

With more U.S., Europe biosimilars continuing to receive FDA/EMA approval, it is critical that bio/pharmaceutical companies develop strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success.

Biosimilars will lead to $54 billion less in direct spending on biologics (or about 3% of total spending on biologics) over the next decade. The range of the new savings estimate given reasonable ranges of key assumptions, such as the price of biosimilars versus reference biologics and biosimilar market share, varied from $24 billion to $150 billion from 2018 through 2027.

The BioTech Pharma Summit: Biosimilars & Biologics 2018 is the leading event to continually stay on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success


Standard rate: 1995€ 15% discount registrations till February 16th 40% discount for 2+ registrations


Diogo Ribeiro

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.